nodes	percent_of_prediction	percent_of_DWPC	metapath
Vidarabine—ADA—Theophylline—asthma	0.229	0.334	CbGbCtD
Vidarabine—ADORA2A—Dyphylline—asthma	0.184	0.269	CbGbCtD
Vidarabine—ADORA2A—Aminophylline—asthma	0.14	0.204	CbGbCtD
Vidarabine—ADORA2A—Theophylline—asthma	0.131	0.192	CbGbCtD
Vidarabine—DPP4—exocrine gland—asthma	0.00451	0.113	CbGeAlD
Vidarabine—ADA—respiratory system—asthma	0.00296	0.0744	CbGeAlD
Vidarabine—DPP4—respiratory system—asthma	0.00235	0.0589	CbGeAlD
Vidarabine—ADA—cardiovascular system—asthma	0.00227	0.057	CbGeAlD
Vidarabine—ADORA2A—cardiovascular system—asthma	0.00207	0.0518	CbGeAlD
Vidarabine—ADK—adrenal cortex—asthma	0.00203	0.051	CbGeAlD
Vidarabine—ADK—bronchus—asthma	0.00199	0.05	CbGeAlD
Vidarabine—DPP4—epithelium—asthma	0.00196	0.0492	CbGeAlD
Vidarabine—ADK—smooth muscle tissue—asthma	0.00195	0.0489	CbGeAlD
Vidarabine—DPP4—smooth muscle tissue—asthma	0.00189	0.0474	CbGeAlD
Vidarabine—ADK—cardiovascular system—asthma	0.00186	0.0465	CbGeAlD
Vidarabine—DPP4—cardiovascular system—asthma	0.0018	0.0451	CbGeAlD
Vidarabine—ADA—adrenal gland—asthma	0.0018	0.0451	CbGeAlD
Vidarabine—ADK—trachea—asthma	0.00179	0.0449	CbGeAlD
Vidarabine—ADORA2A—adrenal gland—asthma	0.00163	0.041	CbGeAlD
Vidarabine—ADA—lung—asthma	0.00157	0.0395	CbGeAlD
Vidarabine—ADK—adrenal gland—asthma	0.00147	0.0368	CbGeAlD
Vidarabine—DPP4—adrenal gland—asthma	0.00142	0.0357	CbGeAlD
Vidarabine—ADK—lung—asthma	0.00129	0.0323	CbGeAlD
Vidarabine—DPP4—lung—asthma	0.00125	0.0313	CbGeAlD
Vidarabine—Azacitidine—DNMT1—asthma	0.00106	0.226	CrCbGaD
Vidarabine—Decitabine—DNMT1—asthma	0.00104	0.221	CrCbGaD
Vidarabine—Glucosamine—IFNG—asthma	0.000904	0.192	CrCbGaD
Vidarabine—Glucosamine—MMP9—asthma	0.000576	0.122	CrCbGaD
Vidarabine—Adenosine monophosphate—PDE4D—asthma	0.000418	0.0889	CrCbGaD
Vidarabine—Glucosamine—TNF—asthma	0.000379	0.0805	CrCbGaD
Vidarabine—Adenosine monophosphate—PDE4B—asthma	0.000327	0.0694	CrCbGaD
Vidarabine—Bradycardia—Prednisolone—asthma	8.95e-05	0.000432	CcSEcCtD
Vidarabine—Acute coronary syndrome—Triamcinolone—asthma	8.88e-05	0.000428	CcSEcCtD
Vidarabine—Acute coronary syndrome—Methylprednisolone—asthma	8.86e-05	0.000427	CcSEcCtD
Vidarabine—Myocardial infarction—Triamcinolone—asthma	8.83e-05	0.000426	CcSEcCtD
Vidarabine—Asthenia—Mometasone—asthma	8.81e-05	0.000425	CcSEcCtD
Vidarabine—Myocardial infarction—Methylprednisolone—asthma	8.81e-05	0.000425	CcSEcCtD
Vidarabine—Cardiac arrest—Prednisone—asthma	8.78e-05	0.000423	CcSEcCtD
Vidarabine—Dizziness—Flunisolide—asthma	8.76e-05	0.000422	CcSEcCtD
Vidarabine—Mood swings—Prednisone—asthma	8.75e-05	0.000422	CcSEcCtD
Vidarabine—Bradycardia—Hydrocortisone—asthma	8.74e-05	0.000421	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—NPS—asthma	8.66e-05	0.00135	CbGpPWpGaD
Vidarabine—Urticaria—Salbutamol—asthma	8.65e-05	0.000417	CcSEcCtD
Vidarabine—Sweating—Methylprednisolone—asthma	8.61e-05	0.000415	CcSEcCtD
Vidarabine—ADK—Metabolism—GSTT1—asthma	8.58e-05	0.00133	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—TACR2—asthma	8.52e-05	0.00132	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR8—asthma	8.52e-05	0.00132	CbGpPWpGaD
Vidarabine—Nausea—Loratadine—asthma	8.5e-05	0.00041	CcSEcCtD
Vidarabine—Hypersensitivity—Arformoterol—asthma	8.49e-05	0.00041	CcSEcCtD
Vidarabine—Hypersensitivity—Formoterol—asthma	8.49e-05	0.00041	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CXCR3—asthma	8.49e-05	0.00132	CbGpPWpGaD
Vidarabine—Nausea—Tiotropium—asthma	8.49e-05	0.000409	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—CD86—asthma	8.47e-05	0.00132	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—NOS2—asthma	8.44e-05	0.00131	CbGpPWpGaD
Vidarabine—Vomiting—Flunisolide—asthma	8.42e-05	0.000406	CcSEcCtD
Vidarabine—Urticaria—Budesonide—asthma	8.38e-05	0.000404	CcSEcCtD
Vidarabine—Rash—Flunisolide—asthma	8.35e-05	0.000403	CcSEcCtD
Vidarabine—Dermatitis—Flunisolide—asthma	8.34e-05	0.000402	CcSEcCtD
Vidarabine—Hypersensitivity—Montelukast—asthma	8.32e-05	0.000401	CcSEcCtD
Vidarabine—Headache—Flunisolide—asthma	8.3e-05	0.0004	CcSEcCtD
Vidarabine—Asthenia—Arformoterol—asthma	8.27e-05	0.000399	CcSEcCtD
Vidarabine—Asthenia—Formoterol—asthma	8.27e-05	0.000399	CcSEcCtD
Vidarabine—Bradycardia—Triamcinolone—asthma	8.23e-05	0.000397	CcSEcCtD
Vidarabine—Bradycardia—Methylprednisolone—asthma	8.21e-05	0.000396	CcSEcCtD
Vidarabine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—asthma	8.16e-05	0.00127	CbGpPWpGaD
Vidarabine—Asthenia—Montelukast—asthma	8.1e-05	0.000391	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—PTGDR2—asthma	8.07e-05	0.00125	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—HRH4—asthma	8.07e-05	0.00125	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—NPSR1—asthma	8.07e-05	0.00125	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PMCH—asthma	8.07e-05	0.00125	CbGpPWpGaD
Vidarabine—Acute coronary syndrome—Betamethasone—asthma	8.05e-05	0.000388	CcSEcCtD
Vidarabine—Acute coronary syndrome—Dexamethasone—asthma	8.05e-05	0.000388	CcSEcCtD
Vidarabine—Hypersensitivity—Salbutamol—asthma	8.02e-05	0.000387	CcSEcCtD
Vidarabine—Myocardial infarction—Betamethasone—asthma	8.01e-05	0.000386	CcSEcCtD
Vidarabine—Myocardial infarction—Dexamethasone—asthma	8.01e-05	0.000386	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CSF2RB—asthma	7.89e-05	0.00123	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALOX5AP—asthma	7.88e-05	0.00123	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALOX15—asthma	7.88e-05	0.00123	CbGpPWpGaD
Vidarabine—Nausea—Flunisolide—asthma	7.87e-05	0.000379	CcSEcCtD
Vidarabine—Arrhythmia—Prednisolone—asthma	7.85e-05	0.000379	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	7.82e-05	0.00122	CbGpPWpGaD
Vidarabine—Asthenia—Salbutamol—asthma	7.81e-05	0.000377	CcSEcCtD
Vidarabine—Vomiting—Mometasone—asthma	7.81e-05	0.000377	CcSEcCtD
Vidarabine—Hypersensitivity—Budesonide—asthma	7.77e-05	0.000375	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—BDKRB2—asthma	7.76e-05	0.00121	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	7.76e-05	0.00121	CbGpPWpGaD
Vidarabine—Rash—Mometasone—asthma	7.74e-05	0.000374	CcSEcCtD
Vidarabine—Dermatitis—Mometasone—asthma	7.74e-05	0.000373	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CCR8—asthma	7.73e-05	0.0012	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—TACR2—asthma	7.73e-05	0.0012	CbGpPWpGaD
Vidarabine—Headache—Mometasone—asthma	7.69e-05	0.000371	CcSEcCtD
Vidarabine—Arrhythmia—Hydrocortisone—asthma	7.67e-05	0.00037	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—PPP2CA—asthma	7.65e-05	0.00119	CbGpPWpGaD
Vidarabine—Dizziness—Arformoterol—asthma	7.62e-05	0.000368	CcSEcCtD
Vidarabine—Dizziness—Formoterol—asthma	7.62e-05	0.000368	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CCL17—asthma	7.58e-05	0.00118	CbGpPWpGaD
Vidarabine—Asthenia—Budesonide—asthma	7.57e-05	0.000365	CcSEcCtD
Vidarabine—ADA—Metabolism—CHAT—asthma	7.52e-05	0.00117	CbGpPWpGaD
Vidarabine—Cardiac disorder—Methylprednisolone—asthma	7.48e-05	0.000361	CcSEcCtD
Vidarabine—Dizziness—Montelukast—asthma	7.47e-05	0.00036	CcSEcCtD
Vidarabine—Bradycardia—Betamethasone—asthma	7.47e-05	0.00036	CcSEcCtD
Vidarabine—Bradycardia—Dexamethasone—asthma	7.47e-05	0.00036	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6R—asthma	7.44e-05	0.00116	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PDE4A—asthma	7.44e-05	0.00116	CbGpPWpGaD
Vidarabine—Vomiting—Formoterol—asthma	7.33e-05	0.000354	CcSEcCtD
Vidarabine—Vomiting—Arformoterol—asthma	7.33e-05	0.000354	CcSEcCtD
Vidarabine—Nausea—Mometasone—asthma	7.3e-05	0.000352	CcSEcCtD
Vidarabine—Rash—Arformoterol—asthma	7.27e-05	0.000351	CcSEcCtD
Vidarabine—Rash—Formoterol—asthma	7.27e-05	0.000351	CcSEcCtD
Vidarabine—Mediastinal disorder—Methylprednisolone—asthma	7.27e-05	0.000351	CcSEcCtD
Vidarabine—Dermatitis—Arformoterol—asthma	7.26e-05	0.00035	CcSEcCtD
Vidarabine—Dermatitis—Formoterol—asthma	7.26e-05	0.00035	CcSEcCtD
Vidarabine—Headache—Formoterol—asthma	7.22e-05	0.000348	CcSEcCtD
Vidarabine—Headache—Arformoterol—asthma	7.22e-05	0.000348	CcSEcCtD
Vidarabine—Arrhythmia—Triamcinolone—asthma	7.22e-05	0.000348	CcSEcCtD
Vidarabine—Vision blurred—Prednisolone—asthma	7.21e-05	0.000348	CcSEcCtD
Vidarabine—Arrhythmia—Methylprednisolone—asthma	7.2e-05	0.000347	CcSEcCtD
Vidarabine—Dizziness—Salbutamol—asthma	7.2e-05	0.000347	CcSEcCtD
Vidarabine—Vomiting—Montelukast—asthma	7.18e-05	0.000346	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—PDGFB—asthma	7.14e-05	0.00111	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NQO1—asthma	7.13e-05	0.00111	CbGpPWpGaD
Vidarabine—Rash—Montelukast—asthma	7.12e-05	0.000343	CcSEcCtD
Vidarabine—Dermatitis—Montelukast—asthma	7.11e-05	0.000343	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—LEP—asthma	7.11e-05	0.00111	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—SERPINE1—asthma	7.11e-05	0.00111	CbGpPWpGaD
Vidarabine—Headache—Montelukast—asthma	7.08e-05	0.000341	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—KNG1—asthma	7.06e-05	0.0011	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—AGTR1—asthma	7.02e-05	0.00109	CbGpPWpGaD
Vidarabine—Acute coronary syndrome—Prednisone—asthma	7.01e-05	0.000338	CcSEcCtD
Vidarabine—Angioedema—Prednisolone—asthma	6.99e-05	0.000337	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	6.99e-05	0.00109	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ADCY2—asthma	6.98e-05	0.00108	CbGpPWpGaD
Vidarabine—Myocardial infarction—Prednisone—asthma	6.97e-05	0.000336	CcSEcCtD
Vidarabine—Dizziness—Budesonide—asthma	6.97e-05	0.000336	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—CYSLTR1—asthma	6.97e-05	0.00108	CbGpPWpGaD
Vidarabine—Vomiting—Salbutamol—asthma	6.92e-05	0.000334	CcSEcCtD
Vidarabine—Dysgeusia—Triamcinolone—asthma	6.89e-05	0.000332	CcSEcCtD
Vidarabine—Rash—Salbutamol—asthma	6.86e-05	0.000331	CcSEcCtD
Vidarabine—Syncope—Prednisolone—asthma	6.86e-05	0.000331	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL10—asthma	6.86e-05	0.00107	CbGpPWpGaD
Vidarabine—Dermatitis—Salbutamol—asthma	6.86e-05	0.000331	CcSEcCtD
Vidarabine—Nausea—Arformoterol—asthma	6.85e-05	0.00033	CcSEcCtD
Vidarabine—Nausea—Formoterol—asthma	6.85e-05	0.00033	CcSEcCtD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—asthma	6.83e-05	0.00106	CbGpPWpGaD
Vidarabine—Angioedema—Hydrocortisone—asthma	6.83e-05	0.000329	CcSEcCtD
Vidarabine—Headache—Salbutamol—asthma	6.82e-05	0.000329	CcSEcCtD
Vidarabine—Back pain—Triamcinolone—asthma	6.81e-05	0.000328	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—PDE4A—asthma	6.76e-05	0.00105	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—VIP—asthma	6.73e-05	0.00105	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—UTS2—asthma	6.73e-05	0.00105	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—C5AR1—asthma	6.73e-05	0.00105	CbGpPWpGaD
Vidarabine—Loss of consciousness—Prednisolone—asthma	6.72e-05	0.000324	CcSEcCtD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—RHOA—asthma	6.72e-05	0.00105	CbGpPWpGaD
Vidarabine—Nausea—Montelukast—asthma	6.71e-05	0.000324	CcSEcCtD
Vidarabine—Vomiting—Budesonide—asthma	6.71e-05	0.000323	CcSEcCtD
Vidarabine—ADA—Metabolism—ALOX5—asthma	6.7e-05	0.00104	CbGpPWpGaD
Vidarabine—Syncope—Hydrocortisone—asthma	6.7e-05	0.000323	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—ADRB2—asthma	6.66e-05	0.00104	CbGpPWpGaD
Vidarabine—Rash—Budesonide—asthma	6.65e-05	0.000321	CcSEcCtD
Vidarabine—Dermatitis—Budesonide—asthma	6.64e-05	0.00032	CcSEcCtD
Vidarabine—Convulsion—Prednisolone—asthma	6.63e-05	0.00032	CcSEcCtD
Vidarabine—Headache—Budesonide—asthma	6.61e-05	0.000319	CcSEcCtD
Vidarabine—Hypertension—Prednisolone—asthma	6.61e-05	0.000319	CcSEcCtD
Vidarabine—Loss of consciousness—Hydrocortisone—asthma	6.57e-05	0.000317	CcSEcCtD
Vidarabine—Arrhythmia—Dexamethasone—asthma	6.55e-05	0.000316	CcSEcCtD
Vidarabine—Arrhythmia—Betamethasone—asthma	6.55e-05	0.000316	CcSEcCtD
Vidarabine—Bradycardia—Prednisone—asthma	6.5e-05	0.000314	CcSEcCtD
Vidarabine—Convulsion—Hydrocortisone—asthma	6.47e-05	0.000312	CcSEcCtD
Vidarabine—Nausea—Salbutamol—asthma	6.47e-05	0.000312	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR4—asthma	6.45e-05	0.001	CbGpPWpGaD
Vidarabine—Hypertension—Hydrocortisone—asthma	6.45e-05	0.000311	CcSEcCtD
Vidarabine—Discomfort—Prednisolone—asthma	6.44e-05	0.00031	CcSEcCtD
Vidarabine—Angioedema—Triamcinolone—asthma	6.43e-05	0.00031	CcSEcCtD
Vidarabine—Angioedema—Methylprednisolone—asthma	6.41e-05	0.000309	CcSEcCtD
Vidarabine—ADA—Metabolism—CARM1—asthma	6.39e-05	0.000994	CbGpPWpGaD
Vidarabine—Anxiety—Hydrocortisone—asthma	6.34e-05	0.000306	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CYSLTR1—asthma	6.33e-05	0.000984	CbGpPWpGaD
Vidarabine—Syncope—Triamcinolone—asthma	6.31e-05	0.000304	CcSEcCtD
Vidarabine—ADA—Metabolism—DCN—asthma	6.3e-05	0.00098	CbGpPWpGaD
Vidarabine—Syncope—Methylprednisolone—asthma	6.3e-05	0.000304	CcSEcCtD
Vidarabine—Discomfort—Hydrocortisone—asthma	6.29e-05	0.000303	CcSEcCtD
Vidarabine—Nausea—Budesonide—asthma	6.26e-05	0.000302	CcSEcCtD
Vidarabine—Anaphylactic shock—Prednisolone—asthma	6.24e-05	0.000301	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—IL2RB—asthma	6.21e-05	0.000966	CbGpPWpGaD
Vidarabine—Loss of consciousness—Triamcinolone—asthma	6.18e-05	0.000298	CcSEcCtD
Vidarabine—Loss of consciousness—Methylprednisolone—asthma	6.17e-05	0.000298	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—PDE4D—asthma	6.16e-05	0.000957	CbGpPWpGaD
Vidarabine—Shock—Prednisolone—asthma	6.14e-05	0.000296	CcSEcCtD
Vidarabine—Cough—Triamcinolone—asthma	6.14e-05	0.000296	CcSEcCtD
Vidarabine—ADA—Metabolism—ALDH2—asthma	6.13e-05	0.000953	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—VIP—asthma	6.11e-05	0.000951	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—C5AR1—asthma	6.11e-05	0.000951	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—UTS2—asthma	6.11e-05	0.000951	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL11—asthma	6.11e-05	0.000951	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—POMC—asthma	6.11e-05	0.00095	CbGpPWpGaD
Vidarabine—Anaphylactic shock—Hydrocortisone—asthma	6.1e-05	0.000294	CcSEcCtD
Vidarabine—Convulsion—Triamcinolone—asthma	6.1e-05	0.000294	CcSEcCtD
Vidarabine—Tachycardia—Prednisolone—asthma	6.09e-05	0.000294	CcSEcCtD
Vidarabine—Convulsion—Methylprednisolone—asthma	6.08e-05	0.000293	CcSEcCtD
Vidarabine—Hypertension—Triamcinolone—asthma	6.07e-05	0.000293	CcSEcCtD
Vidarabine—Hypertension—Methylprednisolone—asthma	6.06e-05	0.000292	CcSEcCtD
Vidarabine—Hyperhidrosis—Prednisolone—asthma	6.04e-05	0.000291	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—C3AR1—asthma	6.03e-05	0.000937	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FCER2—asthma	6.03e-05	0.000937	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—C5—asthma	6e-05	0.000933	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—PDE4B—asthma	6e-05	0.000933	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—TACR1—asthma	6e-05	0.000933	CbGpPWpGaD
Vidarabine—Shock—Hydrocortisone—asthma	6e-05	0.000289	CcSEcCtD
Vidarabine—DPP4—Metabolism of proteins—CCL2—asthma	5.98e-05	0.000929	CbGpPWpGaD
Vidarabine—Anxiety—Methylprednisolone—asthma	5.96e-05	0.000287	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—EDN1—asthma	5.95e-05	0.000926	CbGpPWpGaD
Vidarabine—Tachycardia—Hydrocortisone—asthma	5.95e-05	0.000287	CcSEcCtD
Vidarabine—ADK—Metabolism—GSTP1—asthma	5.95e-05	0.000925	CbGpPWpGaD
Vidarabine—Flushing—Prednisone—asthma	5.93e-05	0.000286	CcSEcCtD
Vidarabine—Discomfort—Triamcinolone—asthma	5.92e-05	0.000285	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCL5—asthma	5.91e-05	0.000918	CbGpPWpGaD
Vidarabine—Discomfort—Methylprednisolone—asthma	5.91e-05	0.000285	CcSEcCtD
Vidarabine—Hyperhidrosis—Hydrocortisone—asthma	5.9e-05	0.000284	CcSEcCtD
Vidarabine—ADA—Circadian rythm related genes—IL6—asthma	5.89e-05	0.000916	CbGpPWpGaD
Vidarabine—ADK—Metabolism—HMOX1—asthma	5.86e-05	0.000912	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR4—asthma	5.86e-05	0.000911	CbGpPWpGaD
Vidarabine—Dry mouth—Triamcinolone—asthma	5.86e-05	0.000283	CcSEcCtD
Vidarabine—ADK—Metabolism—ITPR1—asthma	5.85e-05	0.00091	CbGpPWpGaD
Vidarabine—Angioedema—Dexamethasone—asthma	5.83e-05	0.000281	CcSEcCtD
Vidarabine—Angioedema—Betamethasone—asthma	5.83e-05	0.000281	CcSEcCtD
Vidarabine—ADA—Metabolism—GSTT1—asthma	5.83e-05	0.000907	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CYSLTR2—asthma	5.8e-05	0.000902	CbGpPWpGaD
Vidarabine—ADK—Metabolism—CAT—asthma	5.79e-05	0.0009	CbGpPWpGaD
Vidarabine—Anaphylactic shock—Triamcinolone—asthma	5.74e-05	0.000277	CcSEcCtD
Vidarabine—Anaphylactic shock—Methylprednisolone—asthma	5.73e-05	0.000276	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—IL6R—asthma	5.73e-05	0.00089	CbGpPWpGaD
Vidarabine—Syncope—Betamethasone—asthma	5.73e-05	0.000276	CcSEcCtD
Vidarabine—Syncope—Dexamethasone—asthma	5.73e-05	0.000276	CcSEcCtD
Vidarabine—Arrhythmia—Prednisone—asthma	5.71e-05	0.000275	CcSEcCtD
Vidarabine—Hypotension—Hydrocortisone—asthma	5.7e-05	0.000275	CcSEcCtD
Vidarabine—Shock—Triamcinolone—asthma	5.65e-05	0.000272	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—IL2RB—asthma	5.64e-05	0.000877	CbGpPWpGaD
Vidarabine—Shock—Methylprednisolone—asthma	5.64e-05	0.000272	CcSEcCtD
Vidarabine—Loss of consciousness—Dexamethasone—asthma	5.61e-05	0.000271	CcSEcCtD
Vidarabine—Loss of consciousness—Betamethasone—asthma	5.61e-05	0.000271	CcSEcCtD
Vidarabine—Paraesthesia—Prednisolone—asthma	5.61e-05	0.00027	CcSEcCtD
Vidarabine—Tachycardia—Triamcinolone—asthma	5.6e-05	0.00027	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—PTGDR—asthma	5.6e-05	0.000872	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LTB4R—asthma	5.6e-05	0.000872	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL22—asthma	5.6e-05	0.000872	CbGpPWpGaD
Vidarabine—Tachycardia—Methylprednisolone—asthma	5.59e-05	0.00027	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—PDE4D—asthma	5.59e-05	0.000869	CbGpPWpGaD
Vidarabine—Musculoskeletal discomfort—Hydrocortisone—asthma	5.56e-05	0.000268	CcSEcCtD
Vidarabine—Hyperhidrosis—Triamcinolone—asthma	5.55e-05	0.000268	CcSEcCtD
Vidarabine—Hyperhidrosis—Methylprednisolone—asthma	5.54e-05	0.000267	CcSEcCtD
Vidarabine—Convulsion—Dexamethasone—asthma	5.53e-05	0.000267	CcSEcCtD
Vidarabine—Convulsion—Betamethasone—asthma	5.53e-05	0.000267	CcSEcCtD
Vidarabine—Hypertension—Betamethasone—asthma	5.51e-05	0.000266	CcSEcCtD
Vidarabine—Hypertension—Dexamethasone—asthma	5.51e-05	0.000266	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR3—asthma	5.49e-05	0.000853	CbGpPWpGaD
Vidarabine—Paraesthesia—Hydrocortisone—asthma	5.48e-05	0.000264	CcSEcCtD
Vidarabine—ADK—Metabolism—PLA2G4A—asthma	5.46e-05	0.00085	CbGpPWpGaD
Vidarabine—ADK—Metabolism—GSTM1—asthma	5.46e-05	0.00085	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	5.46e-05	0.000849	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PDE4B—asthma	5.45e-05	0.000847	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—C5—asthma	5.45e-05	0.000847	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—TACR1—asthma	5.45e-05	0.000847	CbGpPWpGaD
Vidarabine—Anxiety—Betamethasone—asthma	5.42e-05	0.000261	CcSEcCtD
Vidarabine—Anxiety—Dexamethasone—asthma	5.42e-05	0.000261	CcSEcCtD
Vidarabine—ADORA2A—Circadian rythm related genes—PTEN—asthma	5.41e-05	0.000842	CbGpPWpGaD
Vidarabine—Discomfort—Dexamethasone—asthma	5.37e-05	0.000259	CcSEcCtD
Vidarabine—Discomfort—Betamethasone—asthma	5.37e-05	0.000259	CcSEcCtD
Vidarabine—Hypotension—Methylprednisolone—asthma	5.35e-05	0.000258	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—NPY—asthma	5.35e-05	0.000832	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	5.34e-05	0.000831	CbGpPWpGaD
Vidarabine—Pain—Prednisolone—asthma	5.34e-05	0.000258	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCR5—asthma	5.32e-05	0.000827	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—asthma	5.31e-05	0.000826	CbGpPWpGaD
Vidarabine—Vision blurred—Prednisone—asthma	5.24e-05	0.000253	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Triamcinolone—asthma	5.23e-05	0.000252	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Methylprednisolone—asthma	5.22e-05	0.000252	CcSEcCtD
Vidarabine—Pain—Hydrocortisone—asthma	5.22e-05	0.000252	CcSEcCtD
Vidarabine—Anaphylactic shock—Dexamethasone—asthma	5.21e-05	0.000251	CcSEcCtD
Vidarabine—Anaphylactic shock—Betamethasone—asthma	5.21e-05	0.000251	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—C3—asthma	5.2e-05	0.000809	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—RHOA—asthma	5.17e-05	0.000804	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AGTR2—asthma	5.16e-05	0.000802	CbGpPWpGaD
Vidarabine—Paraesthesia—Triamcinolone—asthma	5.16e-05	0.000249	CcSEcCtD
Vidarabine—Paraesthesia—Methylprednisolone—asthma	5.14e-05	0.000248	CcSEcCtD
Vidarabine—Shock—Betamethasone—asthma	5.13e-05	0.000247	CcSEcCtD
Vidarabine—Shock—Dexamethasone—asthma	5.13e-05	0.000247	CcSEcCtD
Vidarabine—Dyspnoea—Triamcinolone—asthma	5.12e-05	0.000247	CcSEcCtD
Vidarabine—Agitation—Prednisone—asthma	5.11e-05	0.000246	CcSEcCtD
Vidarabine—Tachycardia—Betamethasone—asthma	5.09e-05	0.000245	CcSEcCtD
Vidarabine—Tachycardia—Dexamethasone—asthma	5.09e-05	0.000245	CcSEcCtD
Vidarabine—Angioedema—Prednisone—asthma	5.08e-05	0.000245	CcSEcCtD
Vidarabine—Hyperhidrosis—Dexamethasone—asthma	5.04e-05	0.000243	CcSEcCtD
Vidarabine—Hyperhidrosis—Betamethasone—asthma	5.04e-05	0.000243	CcSEcCtD
Vidarabine—ADK—Metabolism—PPP2CA—asthma	5.03e-05	0.000782	CbGpPWpGaD
Vidarabine—Syncope—Prednisone—asthma	4.99e-05	0.00024	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CCR3—asthma	4.98e-05	0.000775	CbGpPWpGaD
Vidarabine—Urticaria—Prednisolone—asthma	4.96e-05	0.000239	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—EDNRB—asthma	4.94e-05	0.000768	CbGpPWpGaD
Vidarabine—Pain—Triamcinolone—asthma	4.91e-05	0.000237	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—TAC1—asthma	4.89e-05	0.000761	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—NPS—asthma	4.89e-05	0.000761	CbGpPWpGaD
Vidarabine—Loss of consciousness—Prednisone—asthma	4.89e-05	0.000236	CcSEcCtD
Vidarabine—Hypotension—Dexamethasone—asthma	4.87e-05	0.000235	CcSEcCtD
Vidarabine—Hypotension—Betamethasone—asthma	4.87e-05	0.000235	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—NPY—asthma	4.86e-05	0.000755	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NQO1—asthma	4.85e-05	0.000754	CbGpPWpGaD
Vidarabine—Urticaria—Hydrocortisone—asthma	4.84e-05	0.000234	CcSEcCtD
Vidarabine—Convulsion—Prednisone—asthma	4.82e-05	0.000232	CcSEcCtD
Vidarabine—Hypertension—Prednisone—asthma	4.8e-05	0.000232	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCR3—asthma	4.8e-05	0.000746	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—HRH4—asthma	4.77e-05	0.000741	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTGDR2—asthma	4.77e-05	0.000741	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPSR1—asthma	4.77e-05	0.000741	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PMCH—asthma	4.77e-05	0.000741	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—asthma	4.75e-05	0.000738	CbGpPWpGaD
Vidarabine—Musculoskeletal discomfort—Dexamethasone—asthma	4.75e-05	0.000229	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Betamethasone—asthma	4.75e-05	0.000229	CcSEcCtD
Vidarabine—ADA—Metabolism—ADCY2—asthma	4.74e-05	0.000737	CbGpPWpGaD
Vidarabine—DPP4—Metabolism of proteins—CXCL8—asthma	4.73e-05	0.000735	CbGpPWpGaD
Vidarabine—Anxiety—Prednisone—asthma	4.72e-05	0.000227	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—AGTR2—asthma	4.69e-05	0.000729	CbGpPWpGaD
Vidarabine—Paraesthesia—Dexamethasone—asthma	4.68e-05	0.000226	CcSEcCtD
Vidarabine—Paraesthesia—Betamethasone—asthma	4.68e-05	0.000226	CcSEcCtD
Vidarabine—Discomfort—Prednisone—asthma	4.68e-05	0.000226	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—CSF2RB—asthma	4.66e-05	0.000725	CbGpPWpGaD
Vidarabine—Hypersensitivity—Prednisolone—asthma	4.6e-05	0.000222	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—CCR8—asthma	4.57e-05	0.00071	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TACR2—asthma	4.57e-05	0.00071	CbGpPWpGaD
Vidarabine—Urticaria—Triamcinolone—asthma	4.56e-05	0.00022	CcSEcCtD
Vidarabine—Urticaria—Methylprednisolone—asthma	4.55e-05	0.00022	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—IL5—asthma	4.55e-05	0.000707	CbGpPWpGaD
Vidarabine—Anaphylactic shock—Prednisone—asthma	4.54e-05	0.000219	CcSEcCtD
Vidarabine—Hypersensitivity—Hydrocortisone—asthma	4.49e-05	0.000217	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—EDNRB—asthma	4.49e-05	0.000698	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL17—asthma	4.48e-05	0.000697	CbGpPWpGaD
Vidarabine—Shock—Prednisone—asthma	4.46e-05	0.000215	CcSEcCtD
Vidarabine—Pain—Betamethasone—asthma	4.46e-05	0.000215	CcSEcCtD
Vidarabine—Pain—Dexamethasone—asthma	4.46e-05	0.000215	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—NPS—asthma	4.44e-05	0.000691	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—TAC1—asthma	4.44e-05	0.000691	CbGpPWpGaD
Vidarabine—Tachycardia—Prednisone—asthma	4.43e-05	0.000214	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—BDKRB2—asthma	4.39e-05	0.000682	CbGpPWpGaD
Vidarabine—Hyperhidrosis—Prednisone—asthma	4.39e-05	0.000212	CcSEcCtD
Vidarabine—Asthenia—Hydrocortisone—asthma	4.38e-05	0.000211	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CXCR3—asthma	4.36e-05	0.000677	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—asthma	4.31e-05	0.000671	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—ADCY2—asthma	4.25e-05	0.00066	CbGpPWpGaD
Vidarabine—Hypersensitivity—Triamcinolone—asthma	4.23e-05	0.000204	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—IL3—asthma	4.23e-05	0.000658	CbGpPWpGaD
Vidarabine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	4.22e-05	0.000657	CbGpPWpGaD
Vidarabine—Hypersensitivity—Methylprednisolone—asthma	4.22e-05	0.000204	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—POMC—asthma	4.16e-05	0.000647	CbGpPWpGaD
Vidarabine—Urticaria—Dexamethasone—asthma	4.14e-05	0.0002	CcSEcCtD
Vidarabine—Urticaria—Betamethasone—asthma	4.14e-05	0.0002	CcSEcCtD
Vidarabine—Musculoskeletal discomfort—Prednisone—asthma	4.13e-05	0.000199	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—IL5—asthma	4.13e-05	0.000642	CbGpPWpGaD
Vidarabine—Dizziness—Prednisolone—asthma	4.13e-05	0.000199	CcSEcCtD
Vidarabine—Asthenia—Triamcinolone—asthma	4.12e-05	0.000199	CcSEcCtD
Vidarabine—Asthenia—Methylprednisolone—asthma	4.11e-05	0.000198	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—PTEN—asthma	4.08e-05	0.000635	CbGpPWpGaD
Vidarabine—Paraesthesia—Prednisone—asthma	4.07e-05	0.000197	CcSEcCtD
Vidarabine—ADORA2A—GPCR ligand binding—CCL2—asthma	4.07e-05	0.000633	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTP1—asthma	4.04e-05	0.000628	CbGpPWpGaD
Vidarabine—Dizziness—Hydrocortisone—asthma	4.03e-05	0.000194	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—KIF3A—asthma	3.99e-05	0.000621	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDE4A—asthma	3.99e-05	0.000621	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—KNG1—asthma	3.99e-05	0.000621	CbGpPWpGaD
Vidarabine—ADA—Metabolism—HMOX1—asthma	3.99e-05	0.00062	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—BDKRB2—asthma	3.98e-05	0.00062	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ITPR1—asthma	3.98e-05	0.000618	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—AGTR1—asthma	3.97e-05	0.000617	CbGpPWpGaD
Vidarabine—Rash—Prednisolone—asthma	3.94e-05	0.00019	CcSEcCtD
Vidarabine—Dermatitis—Prednisolone—asthma	3.93e-05	0.00019	CcSEcCtD
Vidarabine—ADA—Metabolism—CAT—asthma	3.93e-05	0.000612	CbGpPWpGaD
Vidarabine—Headache—Prednisolone—asthma	3.91e-05	0.000189	CcSEcCtD
Vidarabine—Vomiting—Hydrocortisone—asthma	3.88e-05	0.000187	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL10—asthma	3.88e-05	0.000603	CbGpPWpGaD
Vidarabine—ADK—Metabolism—POMC—asthma	3.86e-05	0.000601	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADCY2—asthma	3.86e-05	0.0006	CbGpPWpGaD
Vidarabine—Rash—Hydrocortisone—asthma	3.85e-05	0.000185	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—IL3—asthma	3.84e-05	0.000597	CbGpPWpGaD
Vidarabine—Dermatitis—Hydrocortisone—asthma	3.84e-05	0.000185	CcSEcCtD
Vidarabine—Headache—Hydrocortisone—asthma	3.82e-05	0.000184	CcSEcCtD
Vidarabine—Dizziness—Triamcinolone—asthma	3.8e-05	0.000183	CcSEcCtD
Vidarabine—Dizziness—Methylprednisolone—asthma	3.79e-05	0.000183	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—ADRB2—asthma	3.76e-05	0.000585	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CYSLTR1—asthma	3.74e-05	0.000581	CbGpPWpGaD
Vidarabine—Asthenia—Betamethasone—asthma	3.74e-05	0.00018	CcSEcCtD
Vidarabine—Asthenia—Dexamethasone—asthma	3.74e-05	0.00018	CcSEcCtD
Vidarabine—ADA—Metabolism—PLA2G4A—asthma	3.71e-05	0.000578	CbGpPWpGaD
Vidarabine—ADA—Metabolism—GSTM1—asthma	3.71e-05	0.000578	CbGpPWpGaD
Vidarabine—Nausea—Prednisolone—asthma	3.71e-05	0.000179	CcSEcCtD
Vidarabine—ADORA2A—Signaling by NGF—STAT3—asthma	3.65e-05	0.000568	CbGpPWpGaD
Vidarabine—Vomiting—Triamcinolone—asthma	3.65e-05	0.000176	CcSEcCtD
Vidarabine—Vomiting—Methylprednisolone—asthma	3.64e-05	0.000176	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—KNG1—asthma	3.62e-05	0.000564	CbGpPWpGaD
Vidarabine—Nausea—Hydrocortisone—asthma	3.62e-05	0.000175	CcSEcCtD
Vidarabine—Rash—Triamcinolone—asthma	3.62e-05	0.000175	CcSEcCtD
Vidarabine—Dermatitis—Triamcinolone—asthma	3.62e-05	0.000174	CcSEcCtD
Vidarabine—Rash—Methylprednisolone—asthma	3.61e-05	0.000174	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—CCL11—asthma	3.61e-05	0.000562	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CMA1—asthma	3.61e-05	0.000562	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—C5AR1—asthma	3.61e-05	0.000562	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—UTS2—asthma	3.61e-05	0.000562	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VIP—asthma	3.61e-05	0.000562	CbGpPWpGaD
Vidarabine—Dermatitis—Methylprednisolone—asthma	3.61e-05	0.000174	CcSEcCtD
Vidarabine—Urticaria—Prednisone—asthma	3.6e-05	0.000174	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—AGTR1—asthma	3.6e-05	0.00056	CbGpPWpGaD
Vidarabine—Headache—Triamcinolone—asthma	3.6e-05	0.000173	CcSEcCtD
Vidarabine—Headache—Methylprednisolone—asthma	3.59e-05	0.000173	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—ITPR1—asthma	3.56e-05	0.000554	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL10—asthma	3.52e-05	0.000548	CbGpPWpGaD
Vidarabine—ADK—Metabolism—ALB—asthma	3.52e-05	0.000548	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR4—asthma	3.46e-05	0.000538	CbGpPWpGaD
Vidarabine—Dizziness—Dexamethasone—asthma	3.45e-05	0.000166	CcSEcCtD
Vidarabine—Dizziness—Betamethasone—asthma	3.45e-05	0.000166	CcSEcCtD
Vidarabine—ADA—Metabolism—PPP2CA—asthma	3.42e-05	0.000532	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—ADRB2—asthma	3.42e-05	0.000532	CbGpPWpGaD
Vidarabine—Nausea—Triamcinolone—asthma	3.41e-05	0.000165	CcSEcCtD
Vidarabine—Nausea—Methylprednisolone—asthma	3.4e-05	0.000164	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—STAT6—asthma	3.4e-05	0.000528	CbGpPWpGaD
Vidarabine—ADORA2A—Circadian rythm related genes—IL6—asthma	3.38e-05	0.000526	CbGpPWpGaD
Vidarabine—ADK—Metabolism—NOS3—asthma	3.37e-05	0.000524	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—EDN1—asthma	3.36e-05	0.000523	CbGpPWpGaD
Vidarabine—Hypersensitivity—Prednisone—asthma	3.34e-05	0.000161	CcSEcCtD
Vidarabine—ADORA2A—GPCR downstream signaling—CCL5—asthma	3.34e-05	0.000519	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL2RB—asthma	3.33e-05	0.000518	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—EGFR—asthma	3.32e-05	0.000516	CbGpPWpGaD
Vidarabine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—asthma	3.32e-05	0.000516	CbGpPWpGaD
Vidarabine—Vomiting—Betamethasone—asthma	3.31e-05	0.00016	CcSEcCtD
Vidarabine—Vomiting—Dexamethasone—asthma	3.31e-05	0.00016	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—PDE4D—asthma	3.3e-05	0.000514	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CSF2—asthma	3.29e-05	0.000511	CbGpPWpGaD
Vidarabine—Rash—Betamethasone—asthma	3.29e-05	0.000158	CcSEcCtD
Vidarabine—Rash—Dexamethasone—asthma	3.29e-05	0.000158	CcSEcCtD
Vidarabine—Dermatitis—Betamethasone—asthma	3.28e-05	0.000158	CcSEcCtD
Vidarabine—Dermatitis—Dexamethasone—asthma	3.28e-05	0.000158	CcSEcCtD
Vidarabine—Headache—Dexamethasone—asthma	3.26e-05	0.000157	CcSEcCtD
Vidarabine—Headache—Betamethasone—asthma	3.26e-05	0.000157	CcSEcCtD
Vidarabine—Asthenia—Prednisone—asthma	3.26e-05	0.000157	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—ITPR1—asthma	3.23e-05	0.000503	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDE4B—asthma	3.22e-05	0.000501	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—C5—asthma	3.22e-05	0.000501	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TACR1—asthma	3.22e-05	0.000501	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR ligand binding—CXCL8—asthma	3.22e-05	0.0005	CbGpPWpGaD
Vidarabine—Nausea—Betamethasone—asthma	3.09e-05	0.000149	CcSEcCtD
Vidarabine—Nausea—Dexamethasone—asthma	3.09e-05	0.000149	CcSEcCtD
Vidarabine—ADK—Metabolism—PTGS2—asthma	3.08e-05	0.000479	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EDN1—asthma	3.05e-05	0.000475	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL5—asthma	3.03e-05	0.000471	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—PLA2G4A—asthma	3.02e-05	0.00047	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CCR5—asthma	3.01e-05	0.000468	CbGpPWpGaD
Vidarabine—Dizziness—Prednisone—asthma	3e-05	0.000145	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—CSF2—asthma	2.99e-05	0.000464	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IL2RA—asthma	2.96e-05	0.000461	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR3—asthma	2.94e-05	0.000458	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—C3—asthma	2.94e-05	0.000457	CbGpPWpGaD
Vidarabine—Vomiting—Prednisone—asthma	2.89e-05	0.000139	CcSEcCtD
Vidarabine—ADORA2A—Signaling Pathways—NPY—asthma	2.87e-05	0.000446	CbGpPWpGaD
Vidarabine—Rash—Prednisone—asthma	2.86e-05	0.000138	CcSEcCtD
Vidarabine—Dermatitis—Prednisone—asthma	2.86e-05	0.000138	CcSEcCtD
Vidarabine—Headache—Prednisone—asthma	2.84e-05	0.000137	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—PPP2CA—asthma	2.78e-05	0.000432	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGTR2—asthma	2.77e-05	0.00043	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCR5—asthma	2.73e-05	0.000425	CbGpPWpGaD
Vidarabine—Nausea—Prednisone—asthma	2.7e-05	0.00013	CcSEcCtD
Vidarabine—ADORA2A—Signaling by GPCR—IL2RA—asthma	2.69e-05	0.000418	CbGpPWpGaD
Vidarabine—ADK—Metabolism—PTEN—asthma	2.69e-05	0.000418	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—C3—asthma	2.67e-05	0.000415	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDNRB—asthma	2.65e-05	0.000412	CbGpPWpGaD
Vidarabine—ADA—Metabolism—POMC—asthma	2.63e-05	0.000408	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NPS—asthma	2.62e-05	0.000408	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TAC1—asthma	2.62e-05	0.000408	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCR3—asthma	2.57e-05	0.0004	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by NGF—IL6—asthma	2.55e-05	0.000397	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CYBA—asthma	2.49e-05	0.000388	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PARP1—asthma	2.44e-05	0.000379	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL5—asthma	2.44e-05	0.000379	CbGpPWpGaD
Vidarabine—ADA—Metabolism—ALB—asthma	2.39e-05	0.000372	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—BDKRB2—asthma	2.35e-05	0.000366	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—POMC—asthma	2.35e-05	0.000365	CbGpPWpGaD
Vidarabine—ADA—Metabolism—NOS3—asthma	2.29e-05	0.000356	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADCY2—asthma	2.28e-05	0.000354	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL3—asthma	2.27e-05	0.000353	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—KNG1—asthma	2.14e-05	0.000333	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—POMC—asthma	2.13e-05	0.000332	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—AGTR1—asthma	2.13e-05	0.000331	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTGS2—asthma	2.09e-05	0.000326	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CCL2—asthma	2.09e-05	0.000325	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6R—asthma	2.08e-05	0.000324	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL10—asthma	2.08e-05	0.000323	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—RHOA—asthma	2.07e-05	0.000322	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NTRK1—asthma	2.04e-05	0.000317	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ADRB2—asthma	2.02e-05	0.000314	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—ITPR1—asthma	1.91e-05	0.000297	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—RHOA—asthma	1.88e-05	0.000292	CbGpPWpGaD
Vidarabine—ADA—Metabolism—PTEN—asthma	1.83e-05	0.000284	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CD86—asthma	1.82e-05	0.000283	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—CXCL8—asthma	1.82e-05	0.000283	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EDN1—asthma	1.8e-05	0.000281	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL5—asthma	1.79e-05	0.000278	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PLA2G4A—asthma	1.78e-05	0.000277	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CSF2—asthma	1.76e-05	0.000274	CbGpPWpGaD
Vidarabine—ADORA2A—GPCR downstream signaling—IL2—asthma	1.74e-05	0.00027	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SMAD3—asthma	1.72e-05	0.000267	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—CXCL8—asthma	1.65e-05	0.000257	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PPP2CA—asthma	1.64e-05	0.000255	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCR5—asthma	1.61e-05	0.000251	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL2RA—asthma	1.59e-05	0.000247	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL2—asthma	1.58e-05	0.000245	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—C3—asthma	1.58e-05	0.000245	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PDGFB—asthma	1.53e-05	0.000239	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—LEP—asthma	1.47e-05	0.000228	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—FN1—asthma	1.38e-05	0.000215	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—POMC—asthma	1.26e-05	0.000196	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CCL2—asthma	1.23e-05	0.000192	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6R—asthma	1.23e-05	0.000191	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—EGFR—asthma	1.21e-05	0.000188	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—SERPINE1—asthma	1.15e-05	0.000179	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—RHOA—asthma	1.11e-05	0.000173	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—NOS3—asthma	1.1e-05	0.000171	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—CXCL8—asthma	9.75e-06	0.000152	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL2—asthma	9.32e-06	0.000145	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling by GPCR—IL6—asthma	9.27e-06	0.000144	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—MMP9—asthma	8.82e-06	0.000137	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—PTEN—asthma	8.77e-06	0.000136	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—VEGFA—asthma	7.92e-06	0.000123	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—STAT3—asthma	7.84e-06	0.000122	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—TGFB1—asthma	7.27e-06	0.000113	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—EGFR—asthma	7.13e-06	0.000111	CbGpPWpGaD
Vidarabine—ADORA2A—Signaling Pathways—IL6—asthma	5.48e-06	8.52e-05	CbGpPWpGaD
